comprehensive -WSS

comprehensive

author：knowledge 2025-09-28 01:35:28 - browse：2

A view of different flags of the European Union Members. -- first opinion coverage from STAT — Ronald Wittek, Pool Photo via AP

Today, the criteria used to assess the clinical value of new pharmaceuticals and medical devices varies widely across Europe, making it more challenging for biopharma companies to efficiently launch products in multiple countries and contributing to the disparities in access across the continent.

But change is on the horizon: In less than 15 months, the European Union will establish and begin to implement a standardized, pan-EU framework, which all 27 of member states will be required to use to assess the clinical evidence of newly submitted products or devices. A key pillar of the EU’s Regulation on Health Technology Assessment (HTA), the Joint Clinical Assessment (JCA) aims to establish a single, transparent process to reduce redundant practices and bring life science innovation faster to patients in Europe — no matter where they live.

In a longstanding problem in Europe, access to — and the availability of — medication varies across the member states. For example, in Germany, 87% of products approved by the European Medicines Agency (EMA) have full availability (the product gained access on the public reimbursement list without any restrictions to the patient population). In Poland, that figure drops to 8%, according to a report published by the European Federation of Pharmaceutical Industries. Meanwhile, there is a tremendous difference in the gap between an oncology therapy receiving marketing authorization and a formal positive reimbursement decision, ranging from an average of 86 days in Denmark to 981 days in Latvia.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： The thinking behind the controversial eating disorder chatbot Tessa

WSS

Melinda French Gates resigns from Gates Foundation

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Mom launches Girl Scout troop for LGBTQ youth in Texas

H5N1 bird flu virus started spreading in cows in Texas in December

Health care needs a new profession: neuroimaging counseling

knowledge

comprehensive

hotspot

Guidelines to prevent youth baseball injuries need more muscle

The thinking behind the controversial eating disorder chatbot Tessa

23andMe had bad news about my health. I wish a person had delivered it

Why does health care cost so much? A reading guide

Novavax promises a turnaround & Lilly roils the obesity market

Bird flu in milk supply is likely coming from asymptomatic cows

The high cost of giving birth even with insurance

FDA approves first new drug developed for postpartum depression

Hepatitis C has a cure — but many Americans still lack access to it

Bird flu in milk supply is likely coming from asymptomatic cows

leisure time

Bird flu outbreak in cows is latest avian flu curveball

Bird flu outbreak in cows is latest avian flu curveball

Bispecific antibodies are next new thing in cancer immunotherapy

Millions may soon lose Medicaid when they don't have to

Novo: Oral version of Ozempic leads to 15% weight loss

Dogs on Prozac: What pet anti

explore

focus

hotspot

explore